Results 91 to 100 of about 50,884 (170)

Oral Concurrent 1 – Anemia

open access: yes
Pregnancy, Volume 2, Issue S2, September 2026.
wiley   +1 more source

Stability Assessment of Intravenous Iron–Carbohydrate Complexes in Commercial All-in-One Parenteral Nutrition: Potential for Therapeutic Iron Dose Admixing

open access: yesPharmaceutics
Background/Objectives: Iron deficiency and associated iron deficiency anaemia represent a major global health burden. Parenteral nutrition (PN) patients are at increased risk of iron deficiency due to inadequate iron supplementation.
Valentina V. Huwiler   +6 more
doaj   +1 more source

Intravenous Iron Treatment in Pregnancy: Ferric Carboxymaltose for Correction of Iron Deficiency Anaemia

open access: yes, 2017
Iron deficiency is the most common nutritional deficiency state of women in childbearing age. Peri-partum iron deficiency anaemia (IDA) is associated with significant maternal, fetal and infant morbidity.
Dilruba Zeba   +3 more
core   +1 more source

Iron deficiency and von Willebrand disease: the relationship and interdisciplinary approach. A review and own data

open access: yesГинекология
Iron deficiency conditions are common for clinical practice especially in women of reproductive age. In coagulopathies, chronic blood loss, in particular heavy menstrual bleeding, becomes the main cause of iron deficiency anemia.
M. А. Vinogradova
doaj   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

On the safety of intravenous iron, evidence trumps conjecture. [PDF]

open access: yes, 2015
Rampton, D   +61 more
core   +1 more source

Cutaneous Reactions to Iron Infusions: A Case Report and Clinical Review

open access: yeseJHaem
Anemia is prevalent globally and often treated with intravenous (IV) iron formulations, including iron sucrose, iron dextran, ferric carboxymaltose, ferric derisomaltose, and ferumoxytol.
Neil Patil   +6 more
doaj   +1 more source

A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000

open access: yesTherapeutics and Clinical Risk Management, 2011
Sunil BhandariDepartment of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UKBackground: The clinical need to be able to administer high doses of intravenous iron ...
Sunil Bhandari
doaj  

Home - About - Disclaimer - Privacy